Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Menu Back to Drug-Development

Drug Development and Lifecycle Management eLearning Program

Drug Development and Lifecycle Management eLearning Program (all six modules!)

Understand how companies structure their efforts and utilize their resources to improve the odds of successful development, and potentially minimize the risks associated with shepherding a new drug candidate through the development process. Upon completion, you will be able to explain the phases, major work streams, key players and interrelationships necessary to develop new drugs in the US and Europe, and to expand the life cycle of in-line products.

The online program includes six self-paced modules that can be accessed 24 hours a day, 7 days a week. Modules do not have to be taken in one sitting; users can start/stop at any time and begin where they left off. Users will have one year to complete the modules and continuing education credits are offered.

Add Program to Cart

Module 1: Introduction to Drug Development

Learn the activities required to move a drug candidate from idea to the market, and how various functional areas are organized and contribute at each stage of development. Learn about the regulatory environment in which these activities occur.

Learn more

Add Module 1 to Cart

Module 2: Discovery and Pre-Clinical Phases

Learn how companies advance potential drug candidates through the earliest stages of research, from therapeutic target to readiness for clinical studies.

Learn more

Add Module 2 to Cart

Module 3: Drug Development Phase 1

Examine the activities associated with phase 1 development, with a focus on the drivers that impact the design of the first-in-human study.

Learn more

Add Module 3 to Cart

Module 4: Drug Development Phase 2

Learn the factors that drive the design and conduct of phase 2 clinical trials, as well as the activities and functional areas that contribute to a successful phase 2 program.

Learn more

Add Module 4 to Cart

Module 5: Drug Development Phase 3 and Regulatory Review

Review phase 3 clinical study activities and the regulatory requirements and components of an application for marketing approval in the US and EU.

Learn more

Add Module 5 to Cart

Module 6: Drug Development Phase 4 and Lifecycle Management

Review activities associated with the management of a marketed drug, as well as focus on how companies maximize the value of approved products through the lifecycle management process.

Learn more

Add Module 6 to Cart

Related Content

Patient Engagement eLearning Program

Explore the fundamentals of why and how to incorporate patient focus and build organization-wide capabilities.

Learn more

Add to Cart

Product Labeling eLearning Module

Learn how labeling is developed and maintained throughout the product’s marketed life and the components and structure of prescription labeling.

Learn more

Add to Cart

Digital Learning Catalog

DIA Learning: eLearning Soultions

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.